Churchill Capital XIV, a blank check company founded by dealmaker and former Citi executive Michael Klein, filed on Wednesday with the SEC to raise up to $300 million in an initial public offering.
The company plans to raise $300 million by offering 30 million units at $10. Each unit consists of one share of common stock, and one-tenth of one warrant to purchase a share, exercisable at $11.50.
The company is led by CEO and Chairman Michael Klein, the founder and Managing Partner of strategic advisory firm M. Klein and Company. The SPAC veteran previously held various roles at Citi and Salomon Smith Barney. He is joined by CFO Jay Taragin, the CFO of M. Klein and Company.
The SPAC did not indicate a target industry. It plans to target businesses that have recurring revenue, potential to generate stable free cash flow, potential to grow through additional acquisitions, are sourced through Churchill’s proprietary channels, and have a committed and capable management team, among other characteristics.
Klein’s most recent SPACs include Churchill Capital XIII (XIIIU), which went public in July 2026; Churchill Capital XII (CXIIU), which went public in April 2026; Churchill Capital XI (CCXI), which went public in December 2025 and is expected to complete its merger with humanoid robot developer Agility Robotics this week; Churchill Capital X, which merged with quantum computer developer Infleqtion (INFQ) this past February; Churchill Capital Corp IX (CCIX), which went public in 2024 and terminated its planned merger with PlusAI in April 2026; and Churchill Capital Corp VII (CVII), Churchill Capital VI (CCVI.U), and Churchill Capital V (CCV.U), which have all liquidated. Other past SPACs include AltC Acquisition, which merged with SMR developer Oklo (OKLO) in 2024; Churchill Capital Corp IV, which merged with EV maker Lucid (LCID) in 2021; and Churchill Capital Corp III, which merged with healthcare services provider MultiPlan (now Claritev; NYSE: CTEV) in 2020.
The New York, NY-based company was founded in 2026. It plans to list on the Nasdaq under the symbol CXIVU. Citi is the sole bookrunner on the deal.
